AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Food Science and Human Wellness Article
PDF (6 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

High-starchy carbohydrate diet aggravates NAFLD by increasing fatty acids influx mediated by NOX2

Yuqi Gaoa, Rui Huaa, Kezheng Penga, Yuemiao Yina, Chenye Zenga, Yannan Guoa, Yida Wanga, Liyuan Lia, Xue Lib, Ying Qiub, Zhao Wanga( )
MOE Key Laboratory of Protein Sciences, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China
School of Medicine, Tsinghua University, Beijing 100084, China

Peer review under responsibility of KeAi Communications Co., Ltd.

Show Author Information

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a high-incidence lipid disorder that affects more than a quarter of the population worldwide, and dietary intervention is the recognized treatment. Starch is the main component of staple foods that are consumed daily, and the effects, metabolic pathway, and molecular mechanism of starch in the context of NAFLD remain unclear. Our study showed that a high-starch carbohydrate diet (HCD) led to the occurrence and exacerbation of NAFLD in mice. Transcriptomics and metabonomic analyses showed that the increased fatty acid influx mediated by NADPH oxidase 2 (NOX2) exacerbated NAFLD. Knocking down NOX2 specifically alleviated HCD-induced NAFLD in vivo and in vitro. Moreover, the large amounts of ROS produced by NOX2 further exacerbated insulin resistance and increased lipolysis in perirenal white adipose tissue (periWAT), thereby providing fatty acids for hepatic lipid synthesis. In addition, the interaction between AMPKα1 and p47phox was the pathway that mediated the high expression of NOX2 induced by a HCD. Our study systematically demonstrated the effect of a HCD on NAFLD. Elevated fatty acid influx is a unique molecular regulatory pathway that mediates HCD-induced NAFLD exacerbation, which is different from the effect of simple sugars. Additionally, NOX2 was suggested to be a specific and effective drug target for NAFLD.

Keywords

Starchy carbohydratesNonalcoholic fatty liver diseaseNADPH oxidase 2Fatty acid influx

References

[1]

The Lancet Gastroenterology, Redefining non-alcoholic fatty liver disease: what's in a name? Lancet Gastroenterol. Hepatol. 5 (2020) 419. https://doi.org/10.1016/s2468-1253(20)30091-1.
Crossref Google Scholar
[2]

S.K. Sarin, M. Kumar, M. Eslam, et al., Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission, Lancet Gastroenterol. Hepatol. 5 (2020) 167-228. https://doi.org/10.1016/s2468-1253(19)30342-5.
Crossref Google Scholar
[3]

Z.Younossi, Q.M. Anstee, M. Marietti, et al., Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention, Nat. Rev. Gastroenterol. Hepatol. 15 (2018) 11-20. https://doi.org/10.1038/nrgastro.2017.109.
Crossref Google Scholar
[4]

J. Liu, S. Jiang, Y. Zhao, et al., Geranylgeranyl diphosphate synthase (GGPPS) regulates non-alcoholic fatty liver disease (NAFLD)-fibrosis progression by determining hepatic glucose/fatty acid preference under highfat diet conditions, J. Pathol. 246 (2018) 277-288. https://doi.org/10.1002/path.5131.
Crossref Google Scholar
[5]

T. Jensen, M.F. Abdelmalek, S. Sullivan, et al., Fructose and sugar: a major mediator of non-alcoholic fatty liver disease, J. Hepatol. 68 (2018) 1063-1075. https://doi.org/10.1016/j.jhep.2018.01.019.
Crossref Google Scholar
[6]

N. Jones, J. Blagih, F. Zani, et al., Fructose reprogrammes glutaminedependent oxidative metabolism to support LPS-induced inflammation, Nat. Commun. 12 (2021) 1209. https://doi.org/10.1038/s41467-021-21461-4.
Crossref Google Scholar
[7]

Y. Xu, Y. Zhu, S. Hu, et al., Hepatocyte nuclear factor 4α prevents the steatosis-to-NASH progression by regulating p53 and bile acid signaling (in mice), Hepatology 73 (2020) 2251-2265. https://doi.org/10.1002/hep.31604.
Crossref Google Scholar
[8]

J.M. Schwarz, S.M. Noworolski, A.E. Cakmak, et al., Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity, Gastroenterology 153 (2017) 743-752. https://doi.org/10.1053/j.gastro.2017.05.043.
Crossref Google Scholar
[9]

E.C. Jang, D.W. Jun, S.M. Lee, et al., Comparison of efficacy of lowcarbohydrate and low-fat diet education programs in non-alcoholic fatty liver disease: a randomized controlled study, Hepatol. Res. 48 (2018) E22-E29. https://doi.org/10.1111/hepr.12918.
Crossref Google Scholar
[10]

S. Louala, M.L. Senhadji, Beneficial effects of low-calorie-carbohydrate/high-agar diet on cardiometabolic disorders associated with non-alcoholic fatty liver disease in obese rats, Prev. Nutr. Food Sci. 24 (2019) 400-409. https://doi.org/10.3746/pnf.2019.24.4.400.
Crossref Google Scholar
[11]

V.T. Samuel, G.I. Shulman, Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases, Cell Metab. 27 (2018) 22-41. https://doi.org/10.1016/j.cmet.2017.08.002.
Crossref Google Scholar
[12]

H.Y. Järvinen, P.K. Luukkonen, L. Hodson, et al., Dietary carbohydrates and fats in nonalcoholic fatty liver disease, Nat. Rev. Gastroenterol. Hepatol. 18 (2021) 770-786. https://doi.org/10.1038/s41575-021-00472-y.
Crossref Google Scholar
[13]

L. Hodson, P.J. Gunn, The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state, Nat. Rev. Endocrinol. 15 (2019) 689-700. https://doi.org/10.1038/s41574-019-0256-9.
Crossref Google Scholar
[14]

S.Y. Kim, J.M. Jeong, S.J. Kim, et al., Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex, Nat. Commun. 8 (2017) 2247. https://doi.org/10.1038/s41467-017-02325-2.
Crossref Google Scholar
[15]

C.S. Yang, J.J. Kim, S.J. Lee, et al., TLR3-triggered reactive oxygen species contribute to inflammatory responses by activating signal transducer and activator of transcription-1, J. Immunol. 190 (2013) 6368-6377. https://doi.org/10.4049/jimmunol.1202574.
Crossref Google Scholar
[16]

G. Musso, M. Cassader, E. Paschetta, et al., Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis, Gastroenterology 155 (2018) 282-302. https://doi.org/10.1053/j.gastro.2018.06.031.
Crossref Google Scholar
[17]

E. Cremonini, P.I. Oteiza, (–)-Epicatechin and its metabolites prevent palmitate-induced NADPH oxidase upregulation, oxidative stress and insulin resistance in HepG2 cells, Arch. Biochem. Biophys. 646 (2018) 55-63. https://doi.org/10.1016/j.abb.2018.03.027.
Crossref Google Scholar
[18]

A.E. Vendrov, K.C. Vendrov, A. Smith, et al., NOX4 NADPH oxidase-dependent mitochondrial oxidative stress in aging-associated cardiovascular disease, Antioxid.Redox Signal. 23 (2015) 1389-1409. https://doi.org/10.1089/ars.2014.6221.
Crossref Google Scholar
[19]

T. Kietzmann, A. Petry, A. Shvetsova, et al., The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system, Br. J. Pharmacol. 174 (2017) 1533-1554. https://doi.org/10.1111/bph.13792.
Crossref Google Scholar
[20]

K.L. Siu, Q. Li, Y. Zhang, et al., NOX isoforms in the development of abdominal aortic aneurysm, Redox Biol. 11 (2017) 118-125. https://doi.org/10.1016/j.redox.2016.11.002.
Crossref Google Scholar
[21]

U. Förstermann, N. Xia, H. Li, Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis, Circ. Res. 120 (2017) 713-735. https://doi.org/10.1161/circresaha.116.309326.
Crossref Google Scholar
[22]

A. Maqbool, N.T. Watt, N. Haywood, et al., Divergent effects of genetic and pharmacological inhibition of NOX2 NADPH oxidase on insulin resistancerelated vascular damage, Am. J. Physiol. Cell Physiol. 319 (2020) C64-C74. https://doi.org/10.1152/ajpcell.00389.2019.
Crossref Google Scholar
[23]

K. Kim, J. Li, A. Tseng, et al., NOX2 is critical for heterotypic neutrophilplatelet interactions during vascular inflammation, Blood 126 (2015) 1952-1964. https://doi.org/10.1182/blood-2014-10-605261.
Crossref Google Scholar
[24]

H. Buvelot, K.M. Barbe, P. Linder, et al., Staphylococcus aureus, phagocyte NADPH oxidase and chronic granulomatous disease, FEMS Microbiol. Rev. 41 (2017) 139-157. https://doi.org/10.1093/femsre/fuw042.
Crossref Google Scholar
[25]

P.L. Hordijk, Regulation of NADPH oxidases: the role of Rac proteins, Circ. Res. 98 (2006) 453-462. https://doi.org/10.1161/01.RES.0000204727.46710.5e.
Crossref Google Scholar
[26]

C.H. Olguin, J.R. Knudsen, S.H. Raun, et al., Cytosolic ROS production by NADPH oxidase 2 regulates muscle glucose uptake during exercise, Nat. Commun. 10 (2019) 4623. https://doi.org/10.1038/s41467-019-12523-9.
Crossref Google Scholar
[27]

L. Loffredo, A.M. Zicari, L. Perri, et al., Does NOX2 overactivate in children with nonalcoholic fatty liver disease? Antioxid.Redox Signal. 30 (2019) 1325-1330. https://doi.org/10.1089/ars.2018.7596.
Crossref Google Scholar
[28]

E. Grossini, D.P. Garhwal, G. Calamita, et al., Exposure to plasma from non-alcoholic fatty liver disease patients affects hepatocyte viability, generates mitochondrial dysfunction, and modulates pathways involved in fat accumulation and inflammation, Front. Med. 8 (2021) 693997. https://doi.org/10.3389/fmed.2021.693997.
Crossref Google Scholar
[29]

R. Peng, M. Luo, R. Tian, et al., Dietary nitrate attenuated endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: a critical role for NADPH oxidase, Arch. Biochem. Biophys. 689 (2020) 108453. https://doi.org/10.1016/j.abb.2020.108453.
Crossref Google Scholar
[30]

P. Pignatelli, R. Carnevale, D. Pastori, et al., Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of NOX2, Circulation 126 (2012) 92-103. https://doi.org/10.1161/circulationaha.112.095554.
Crossref Google Scholar
[31]

M.J. Ronis, N. Sharma, J. Vantrease, et al., Female mice lacking p47phox have altered adipose tissue gene expression and are protected against high fat-induced obesity, Physiol. Genomics 45 (2013) 351-366. https://doi.org/10.1152/physiolgenomics.00148.2012.
Crossref Google Scholar
[32]

S.K. Shin, K.O. Kim, S.H. Kim, et al., Exogenous 8-hydroxydeoxyguanosine ameliorates liver fibrosis through the inhibition of Rac1-NADPH oxidase signaling, J. Gastroenterol. Hepatol. 35 (2020) 1078-1087. https://doi.org/10.1111/jgh.14979.
Crossref Google Scholar
[33]

E. Cremonini, P.I. Oteiza, (–)-Epicatechin and its metabolites prevent palmitate-induced NADPH oxidase upregulation, oxidative stress and insulin resistance in HepG2 cells, Arch. Biochem. Biophys. 646 (2018) 55-63. https://doi.org/10.1016/j.abb.2018.03.027.
Crossref Google Scholar
[34]

A. Figueiredo, A.B. Salmon, F. Bruno, et al., NOX2 mediates skeletal muscle insulin resistance induced by a high fat diet, J. Biol. Chem. 290 (2015) 13427-13439. https://doi.org/10.1074/jbc.M114.626077.
Crossref Google Scholar
[35]

P.G. Reeves, F.H. Nielsen, G.C. Fahey, AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet, J. Nutr. 123 (1993) 1939-1951. https://doi.org/10.1093/jn/123.11.1939.
Crossref Google Scholar
[36]

J. Ye, J.Z. Li, Y. Liu, et al., Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B, Cell Metab. 9 (2009) 177-190. https://doi.org/10.1016/j.cmet.2008.12.013.
Crossref Google Scholar
[37]

H. Chen, S. Gao, W. Liu, et al., RNA N(6)-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6)A-GLUT1-mTORC1 axis and is a therapeutic target, Gastroenterology 160 (2021) 1284-1300. https://doi.org/10.1053/j.gastro.2020.11.013.
Crossref Google Scholar
[38]

E.V. Gomez, N. Chalasani, Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers, J. Hepatol. 68 (2018) 305-315. https://doi.org/10.1016/j.jhep.2017.11.013.
Crossref Google Scholar
[39]

C.M. Anderson, A. Stahl, SLC27 fatty acid transport proteins, Mol. Aspects Med. 34 (2013) 516-528. https://doi.org/10.1016/j.mam.2012.07.010.
Crossref Google Scholar
[40]

D. Gallardo, M. Amills, R. Quintanilla, et al., Mapping and tissue mRNA expression analysis of the pig solute carrier 27A (SLC27A) multigene family, Gene 515 (2013) 220-223. https://doi.org/10.1016/j.gene.2012.11.029.
Crossref Google Scholar
[41]

P. Dourlen, A. Sujkowski, R. Wessells, et al., Fatty acid transport proteins in disease: new insights from invertebrate models, Prog. Lipid Res. 60 (2015) 30-40. https://doi.org/10.1016/j.plipres.2015.08.001.
Crossref Google Scholar
[42]

T. Mishima, J.H. Miner, M. Morizane, et al., The expression and function of fatty acid transport protein-2 and -4 in the murine placenta, PLoS One 6 (2011) e25865. https://doi.org/10.1371/journal.pone.0025865.
Crossref Google Scholar
[43]

A. Stahl, R.E. Gimeno, L.A. Tartaglia, et al., Fatty acid transport proteins: a current view of a growing family, Trends Endocrinol. Metab. 12 (2001) 266-273. https://doi.org/10.1016/s1043-2760(01)00427-1.
Crossref Google Scholar
[44]

R. Mallick, S. Basak, A.K. Duttaroy, Fatty acids and evolving roles of their proteins in neurological, cardiovascular disorders and cancers, Prog. Lipid Res. 83 (2021) 101116. https://doi.org/10.1016/j.plipres.2021.101116.
Crossref Google Scholar
[45]

L.P. Bechmann, R.K. Gieseler, J.P. Sowa, et al., Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis, Liver Int. 30 (2010) 850-859. https://doi.org/10.1111/j.1478-3231.2010.02248.x.
Crossref Google Scholar
[46]

M.E. Colina, E.L. Cabello, S.S. Campos, et al., Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C, Gut 60 (2011) 1394-1402. https://doi.org/10.1136/gut.2010.222844.
Crossref Google Scholar
[47]

Y. Song, J. Liu, K. Zhao, et al., Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases, Cell Metab. 33 (2021) 1911-1925. https://doi.org/10.1016/j.cmet.2021.09.001.
Crossref Google Scholar
[48]

C. Chen, H. Li, J. Song, et al., Role of apolipoprotein A1 in PPAR signaling pathway for nonalcoholic fatty liver disease, PPAR Res. 2022 (2022) 4709300. https://doi.org/10.1155/2022/4709300.
Crossref Google Scholar
[49]

Y.Q. Chen, T.G. Pottanat, E.Y. Zhen, et al., ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition, J. Lipid Res. 62 (2021) 100068. https://doi.org/10.1016/j.jlr.2021.100068.
Crossref Google Scholar
[50]

M. Balteau, A.V. Steenbergen, A.D. Timmermans, et al., AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes, Am. J. Physiol. Heart Circ. Physiol. 307 (2014) 1120-1133. https://doi.org/10.1152/ajpheart.00210.2014.
Crossref Google Scholar
[51]

I. Levin, J. Petrasek, G. Szabo, The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis, Alcohol. Clin. Exp. Res. 36 (2012) 1397-1406. https://doi.org/10.1111/j.1530-0277.2012.01739.x.
Crossref Google Scholar
[52]

M. Taura, K. Miyano, R. Minakami, et al., A region N-terminal to the tandem SH3 domain of p47phox plays a crucial role in the activation of the phagocyte NADPH oxidase, Biochem. J. 419 (2009) 329-338. https://doi.org/10.1042/bj20082028.
Crossref Google Scholar
[53]

J.X. Chen, A. Stinnett, Critical role of the NADPH oxidase subunit p47phox on vascular TLR expression and neointimal lesion formation in high-fat dietinduced obesity, Lab. Invest. 88 (2008) 1316-1328. https://doi.org/10.1038/labinvest.2008.92.
Crossref Google Scholar
[54]

S. Bunbupha, P. Prasarttong, A. Poasakate, et al., Imperatorin alleviates metabolic and vascular alterations in high-fat/high-fructose dietfed rats by modulating adiponectin receptor 1, eNOS, and p47(phox) expression, Eur. J. Pharmacol. 899 (2021) 174010. https://doi.org/10.1016/j.ejphar.2021.174010.
Crossref Google Scholar
[55]

Y.A. An, S. Chen, Y. Deng, et al., The mitochondrial dicarboxylate carrier prevents hepatic lipotoxicity by inhibiting white adipocyte lipolysis, J. Hepatol. 75 (2021) 387-399. https://doi.org/10.1016/j.jhep.2021.03.006.
Crossref Google Scholar
[56]

M.C. Petersen, G.I. Shulman, Mechanisms of insulin action and insulin resistance, Physiol. Rev. 98 (2018) 2133-2223. https://doi.org/10.1152/physrev.00063.2017.
Crossref Google Scholar
[57]

N. Li, B. Li, T. Brun, et al., NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion, Diabetes 61 (2012) 2842-2850. https://doi.org/10.2337/db12-0009.
Crossref Google Scholar
[58]

W. Gao, X. Du, L. Lei, et al., NEFA-induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in nonalcoholic steatohepatitis, J. Cell. Mol. Med. 22 (2018) 3408-3422. https://doi.org/10.1111/jcmm.13617.
Crossref Google Scholar
[59]

P. Jiang, L. Ren, L. Zhi, et al., Negative regulation of AMPK signaling by high glucose via E3 ubiquitin ligase MG53, Mol. Cell 81 (2021) 629-637. https://doi.org/10.1016/j.molcel.2020.12.008.
Crossref Google Scholar
[60]

H.J. Lee, D.Y. Lee, M.M. Mariappan, et al., Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells, J. Biol. Chem. 292 (2017) 5665-5675. https://doi.org/10.1074/jbc.M116.766758.
Crossref Google Scholar
[61]

P.W. Cheng, W.Y. Ho, Y.T. Su, et al., Resveratrol decreases fructoseinduced oxidative stress, mediated by NADPH oxidase via an AMPKdependent mechanism, Br. J. Pharmacol. 171 (2014) 2739-2750. https://doi.org/10.1111/bph.12648.
Crossref Google Scholar
[62]

L.B. Torres, K.A. Fortner, P. Iruzubieta, et al., Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation, Nat. Commun. 11 (2020) 3360. https://doi.org/10.1038/s41467-020-16991-2.
Crossref Google Scholar
[63]

G.N. Zhao, P. Zhang, J. Gong, et al., Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4, Nat. Med. 23 (2017) 742-752. https://doi.org/10.1038/nm.4334.
Crossref Google Scholar
[64]

H.Y. Järvinen, P.K. Luukkonen, L. Hodson, et al., Dietary carbohydrates and fats in nonalcoholic fatty liver disease, Nat. Rev. Gastroenterol. Hepatol. 18 (2021) 770-786. https://doi.org/10.1038/s41575-021-00472-y.
Crossref Google Scholar
[65]

F. Angelico, L. Loffredo, P. Pignatelli, et al., Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome, Int. Emerg. Med. 7 (2012) 219-227. https://doi.org/10.1007/s11739-011-0591-x.
Crossref Google Scholar
[66]

C. Nagata, K. Wada, M. Yamakawa, et al., Intake of starch and sugars and total and cause-specific mortality in a Japanese community: the Takayama Study, Br. J. Nutr. 122 (2019) 820-828. https://doi.org/10.1017/s0007114519001661.
Crossref Google Scholar
[67]

M. Yamakawa, K. Wada, S. Koda, et al., High intake of free sugars, fructose, and sucrose is associated with weight gain in Japanese men, J. Nutr. 150 (2020) 322-330. https://doi.org/10.1093/jn/nxz227.
Crossref Google Scholar
[68]

F.J. Warren, B. Zhang, G. Waltzer, et al., The interplay of α-amylase and amyloglucosidase activities on the digestion of starch in in vitro enzymic systems, Carbohydr. Polym. 117 (2015) 192-200. https://doi.org/10.1016/j.carbpol.2014.09.043.
Crossref Google Scholar
[69]

J. Nadia, J. Bronlund, R.P. Singh, et al., Structural breakdown of starch-based foods during gastric digestion and its link to glycemic response: in vivo and in vitro considerations, Compr. Rev. Food Sci. F. 20 (2021) 2660-2698. https://doi.org/10.1111/1541-4337.12749.
Crossref Google Scholar
[70]

I.S. Surono, J. Verhoeven, K. Venema, Low glycemic load after digestion of native starch from the indigenous tuber Belitung Taro (Xanthosoma sagittifolium) in a dynamic in vitro model of the upper GI tract (TIM-1), Food Nutr. Res. 64 (2020) 4623. https://doi.org/10.29219/fnr.v64.4623.
Crossref Google Scholar
[71]

M. Yaman, H.S. Sargın, F. MızrakÖ, Free sugar content, in vitro starch digestibility and predicted glycemic index of ready-to-eat breakfast cereals commonly consumed in Turkey: an evaluation of nutritional quality, Int. J. Biol. Macromol. 135 (2019) 1082-1087. https://doi.org/10.1016/j.ijbiomac.2019.06.037.
Crossref Google Scholar
[72]

X. Xiao, X. Zhang, J. Bai, et al., Bisphenol S increases the obesogenic effects of a high-glucose diet through regulating lipid metabolism in Caenorhabditis elegans, Food Chem. 339 (2021) 127813. https://doi.org/10.1016/j.foodchem.2020.127813.
Crossref Google Scholar
[73]

S. Softic, M.K. Gupta, G.X. Wang, et al., Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling, J. Clin. Investig. 128 (2018) 1199. https://doi.org/10.1172/jci99009.
Crossref Google Scholar
[74]

H.Y. Yang, M. Liu, Y. Sheng, et al., All-trans retinoic acid impairs glucosestimulated insulin secretion by activating the RXR/SREBP-1c/UCP2 pathway, Acta Pharmacol. Sin. 43 (2021) 1441-1452. https://doi.org/10.1038/s41401-021-00740-2.
Crossref Google Scholar
[75]

J. Hao, L. Zhu, S. Zhao, et al., PTEN ameliorates high glucose-induced lipid deposits through regulating SREBP-1/FASN/ACC pathway in renal proximal tubular cells, Exp. Cell Res. 317 (2011) 1629-1639. https://doi.org/10.1016/j.yexcr.2011.02.003.
Crossref Google Scholar
[76]

A.G. Linden, S. Li, H.Y. Choi, et al., Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice, J. Lipid Res. 59 (2018) 475-487. https://doi.org/10.1194/jlr.M081836.
Crossref Google Scholar
[77]

K. Iizuka, K. Takao, D. Yabe, ChREBP-mediated regulation of lipid metabolism: involvement of the gut microbiota, liver, and adipose tissue, Front. Endocrinol. 11 (2020) 587189. https://doi.org/10.3389/fendo.2020.587189.
Crossref Google Scholar
[78]

F. Rajas, R. Dentin, A.C. Miliano, et al., The absence of hepatic glucose-6 phosphatase/ChREBP couple is incompatible with survival in mice, Mol. Metab. 43 (2021) 101108. https://doi.org/10.1016/j.molmet.2020.101108.
Crossref Google Scholar
[79]

Y.M. Wang, H.X. Liu, N.Y. Fang, High glucose concentration impairs 5-PAHSA activity by inhibiting AMP-activated protein kinase activation and promoting nuclear factor-kappa-B-mediated inflammation, Front. Pharmacol. 9 (2018) 1491. https://doi.org/10.3389/fphar.2018.01491.
Crossref Google Scholar
[80]

H. Hosseini, M. Teimouri, M. Shabani, et al., Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway, Int. J. Biochem. Cell Biol. 119 (2020) 105667. https://doi.org/10.1016/j.biocel.2019.105667.
Crossref Google Scholar
[81]

C.Q. Lai, L.D. Parnell, C.E. Smith, et al., Carbohydrate and fat intake associated with risk of metabolic diseases through epigenetics of CPT1A, Am. J. Clin. Nutr. 112 (2020) 1200-1211. https://doi.org/10.1093/ajcn/nqaa233.
Crossref Google Scholar
[82]

L. Mirarchi, S. Amodeo, R. Citarrella, et al., SGLT2 inhibitors as the most promising influencers on the outcome of non-alcoholic fatty liver disease, Int. J. Mol. Sci. 23 (2022). https://doi.org/10.3390/ijms23073668.
Crossref Google Scholar
[83]

C. Orhan, M. Tuzcu, P.B. Deeh, et al., Organic chromium form alleviates the detrimental effects of heat stress on nutrient digestibility and nutrient transporters in laying hens, Biol. Trace Elem. Res. 189 (2019) 529-537. https://doi.org/10.1007/s12011-018-1485-9.
Crossref Google Scholar
[84]

S.G. Resines, P.J. Quinn, R.J. Naftalin, et al., Multiple interactions of glucose with the extra-membranous loops of GLUT1 aid transport, J. Chem. Inf. Model. 61 (2021) 3559-3570. https://doi.org/10.1021/acs.jcim.1c00310.
Crossref Google Scholar
Food Science and Human Wellness
Volume 12 Issue 4,
July 2023
Pages 1081-1101
DOI: 10.1016/j.fshw.2022.10.026
Cite this article:
Gao Y, Hua R, Peng K, et al. High-starchy carbohydrate diet aggravates NAFLD by increasing fatty acids influx mediated by NOX2. Food Science and Human Wellness, 2023, 12(4): 1081-1101. https://doi.org/10.1016/j.fshw.2022.10.026

706

Views

65

Downloads

12

Crossref

11

Web of Science

11

Scopus

0

CSCD

Altmetrics
Received: 23 March 2022
Revised: 25 April 2022
Accepted: 23 May 2022
Published: 18 November 2022
© 2023 Beijing Academy of Food Sciences. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return